Mar 1, 2022 7:00 am EST Profound Medical’s TULSA-PRO® Now Compatible with GE Healthcare’s 3T MRI Scanners
Feb 10, 2022 4:30 pm EST Profound Medical to Release Fourth Quarter and Full Year 2021 Financial Results on March 3 – Conference Call to Follow
Feb 8, 2022 4:30 pm EST Profound Medical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference
Jan 18, 2022 7:33 am EST Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy
Oct 18, 2021 4:45 pm EDT Profound Medical to Release Third Quarter 2021 Financial Results on November 4 – Conference Call to Follow